Navigation Links
Baylor Hamilton Heart Hospital Honored for Innovative Rehabilitation Program
Date:12/11/2009

DALLAS, Dec. 11 /PRNewswire-USNewswire/ -- For their unique Return to Work Lab which focuses on individualized rehabilitation for younger, more active cardiac patients, the Cardiac Rehabilitation program at the Baylor Jack and Jane Hamilton Heart and Vascular Hospital was recently awarded the Innovation Award from the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). The award acknowledges programs that have enhanced their delivery of care for a patient population in a unique and creative way, beyond the traditional model of cardiac and pulmonary rehabilitation.

"We realize that a traditional cardiac rehabilitation program of moderate exercises on the treadmill and light weights may work for some patients," said Danielle Strauss, RN, program manager. "However, our industrial athletes -- individuals who perform strenuous activities throughout the day --require a more intense level of training to prepare them to return to physically demanding jobs, such as firefighting and police work."

The goal of the Return to Work Lab, a program funded by the Harry S. Moss Heart Fund at the Baylor Health Care System Foundation, is to create specialized programs for industrial athletes to ensure they are safe and healthy when they return to their jobs and active lifestyles.

"We are seeing younger and younger cardiac patients at the Baylor Hamilton Heart and Vascular Hospital, and many of these patients opt out of rehab because they don't think it will adequately meet their goals," said hospital president Nancy Vish, RN, Ph.D. "Failure to participate in rehabilitation training increases the likelihood that they will experience another cardiac event when they return to work."

Return to Work Lab staff members assess the activities patients perform in their daily lives and design programs to appropriately increase their heart rate and MET levels so they can return to their active lifestyles. The pr
'/>"/>

SOURCE Baylor Health Care System
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institutes 25th Anniversary
2. Baylor Sammons Cancer Center Joins One of Nations Largest Cancer Clinical Trials Groups
3. Baylor University Medical Center at Dallas Recognized for Exemplary Surgical Patient Care
4. Sleep Center at Baylor Dallas One of Select Centers in North Texas to Receive Accreditation
5. Sammons Support for Baylor Health Care System Foundation Tops $20 Million
6. Baylor Health Care System Named Among 2009 Best Places to Work in Healthcare
7. Baylor University Economists Call for Different Tack on Health Care Insurance
8. Unified360 Makes Positive Impact to Baylor Surgical Center Operations.
9. Baylor Dallas Recognized In U.S. News Media Groups 2009 - 2010 Americas Best Hospitals
10. Baylor Dallas Opens Nations First Neurosurgical OR Suite Featuring BrainSUITE iMRI, GE Healthcare MR Surgical Technology
11. Baylor Research Institute Receives Multi-Million Dollar Grant To Develop Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... been working in the garment industry for decades, LunaDress’ dress ... James, one of the company’s top designers, many ladies like ... that add beauty to them. Chiffon floor length outfits are ... new selection of 2014 long prom dresses. , As ... available in over 20 popular designs. The company intends to ...
(Date:10/19/2014)... 20, 2014 Recently, Fancyflyingfox.com, an innovative ... clothes, has announced its latest designs of 2014 ... the new elegant outfits are offered with big discounts, ... order before October 30 can enjoy this special offer. ... marketing strategies, it has become one of the leading ...
(Date:10/19/2014)... NC (PRWEB) October 19, 2014 ... building program has just been released to the ... the online body building and fitness community. The ... attention of DietsAndFitnessGuides.com's Vin Delmonico prompting an investigative ... experience of hitting what is commonly known as ...
(Date:10/19/2014)... Oct. 19, 2014 (HealthDay News) -- New stem cell-based ... lead to new treatments, a new study suggests. ... human intestinal tissue in a lab dish. They then ... for studying intestinal disorders, according to the researchers. ... diseases and conditions that can cause intestinal failure, from ...
(Date:10/19/2014)... – The U.S. Government has initiated a major ... by 2025. However, a workgroup of nearly 40 ... in the U.S. Government,s National Plan to Address ... in scale, and adequately funded in order to ... by the workgroup to enlarge and strengthen the ...
Breaking Medicine News(10 mins):Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 3Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 4Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 5Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 6
... published insight into the biology of many kinds of less-aggressive ... wide array of possibilities for new therapies, according to scientists ... (UCSF). In paper published online Dec. 15 in the ... a genetic mutation leads to an abnormal metabolic process in ...
... happy holiday thought, but an important one: The number of ... surges by 33 percent on New Year,s Day. The suspected ... by sociologist David Phillips of the University of California, San ... on New Year,s is published in the journal Addiction ...
... Reporter , WEDNESDAY, Dec. 15 (HealthDay News) -- In a rare ... AIDS no longer has any detectable HIV cells in his blood ... But experts were quick to caution that the case ... As it turns out, the donor for that transplant ...
... HealthDay Reporter , WEDNESDAY, Dec. 15 (HealthDay News) -- Making ... diagnosis is not only unnecessary but may make it less likely ... a new study finds. Researchers reviewed records from the New ... who had been declared brain dead. All of the people had ...
... ICELAND, 15 December 2010 Scientists from deCODE genetics ... Spain and Romania today report the discovery of a ... human genome (SNPs) that impact individual baseline levels of ... is the most commonly used screening tool for the ...
... The recently identified TRIM24 protein plays an active role ... and, potentially, into breast cancer. Reporting in the ... at The University of Texas MD Anderson Cancer Center ... toward active expression. This expression, in turn, sets the ...
Cached Medicine News:Health News:Insight offers new angle of attack on variety of brain tumors 2Health News:Insight offers new angle of attack on variety of brain tumors 3Health News:SIDS spikes on New Year's Day 2Health News:Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution 2Health News:Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution 3Health News:Second Brain Death Exam Unnecessary, Study Finds 2Health News:Second Brain Death Exam Unnecessary, Study Finds 3Health News:deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer 2Health News:Protein disables p53, drives breast cells toward cancer transition 2Health News:Protein disables p53, drives breast cells toward cancer transition 3
(Date:10/17/2014)... , October 17, 2014 Investor-Edge ... Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals Inc. ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 16, 2014, ended on a mixed ...
(Date:10/17/2014)... Wash. , Oct. 17, 2014  Talyst, a ... the 2014 LeadingAge Annual Meeting in Nashville, ... InSite System, the market leading solution for onsite, remote ... long term care facilities to safely and securely dispense ... time to first dose, helps ensure that the correct ...
(Date:10/17/2014)... , Oct. 17, 2014   InnFocus, Inc ., reported ... the United States for up to 3 years ... Summit in Chicago . The ... of the annual meeting of the American Academy of ... treated approximately 150 glaucoma patients in 6 countries by early ...
Breaking Medicine Technology:Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5Talyst Exhibits at LeadingAge Annual Meeting 2InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 2
... PHILADELPHIA and LONDON , June 28 ... portfolio of drugs, whilst the proportion of total sales from newer drugs ... Factbook complied by CMR International, a Thomson Reuters business. , ... The new edition of the R&D Factbook ...
... Fla. , June 26 Data ... that linagliptin achieved statistically significant and sustained reductions ... (HbA1c),(1-4) fasting plasma glucose (FPG)(1-4) and postprandial glucose ... dipeptidyl peptidase 4 (DPP-4) inhibitor as an oral ...
Cached Medicine Technology:Global Pharmaceutical R&D Productivity Declining According to Thomson Reuters, CMR International 2Global Pharmaceutical R&D Productivity Declining According to Thomson Reuters, CMR International 3Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 2Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 3Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 4Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 5Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 6Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 7Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 8
Anti-PR3 EIA Auto-Immune Markers 013-PR3-96 Proteinase...
... For the quantitative determination of ... ,Patients with atopic allergic diseases such ... fever have been shown to exhibit ... blood. IgE is also known as ...
... growth factor 1 (IGF-1) is a polypeptide of ... of a number of related insulin-like growth factors ... 50% sequence homology with proinsulin and has a ... peptide is growth hormone (GH) dependent to a ...
...
Medicine Products: